Stock Taper 
RHENMAN & PARTNERS ASSET MANAGEMENT AB
Latest 13F filing data - Q2 2026
Holdings
(Top positions)| STOCK | TICKER | SHARES HELD▲ ▼ | VALUE▲ ▼ |
|---|---|---|---|
 Alignment Healthcare, Inc. | ALHC | 997.08K | $23.74M |
 Nurix Therapeutics, Inc. | NRIX | 684.25K | $16.6M |
 Kura Oncology, Inc. | KURA | 591.5K | $6.49M |
 Relay Therapeutics, Inc. | RLAY | 566K | $10.59M |
 Syndax Pharmaceuticals, Inc. | SNDX | 560.25K | $12.25M |
 Boston Scientific Corporation | BSX | 450.5K | $19.23M |
 Mineralys Therapeutics, Inc. | MLYS | 416.37K | $11.23M |
 Oscar Health, Inc. | OSCR | 392K | $11.18M |
 MoonLake Immunotherapeutics | MLTX | 384.8K | $7.49M |
 The Pennant Group, Inc. | PNTG | 371.47K | $13.73M |
 Erasca, Inc. | ERAS | 349K | $6.39M |
 PROCEPT BioRobotics Corporation | PRCT | 345K | $7.79M |
 IDEAYA Biosciences, Inc. | IDYA | 343.8K | $12.81M |
 Stevanato Group S.p.A. | STVN | 305.97K | $5.53M |
 BioMarin Pharmaceutical Inc. | BMRN | 290.5K | $16.62M |
 CVS Health Corp. | CVS | 279.37K | $28.9M |
 Edwards Lifesciences Corporation | EW | 260K | $23.52M |
 Centene Corp. | CNC | 244K | $15.66M |
 Ocular Therapeutix, Inc. | OCUL | 225K | $2.21M |
 Merck & Co., Inc. | MRK | 213.5K | $27.43M |